ZFP36 and prostate carcinoma: To determine if reduced levels of TTP mRNA might be a hallmark of aggressive prostate cancers we initially analyzed a gene expression dataset of 131 primary and 19 metastatic human prostate cancer samples (GSE21034) [15].